SAN

84.96

+0.38%↑

MRK1

120.5

+0.84%↑

SHL.DE

43.39

+1.97%↑

ARGX

769.8

-2.73%↓

PHIA

23.33

+2.73%↑

SAN

84.96

+0.38%↑

MRK1

120.5

+0.84%↑

SHL.DE

43.39

+1.97%↑

ARGX

769.8

-2.73%↓

PHIA

23.33

+2.73%↑

SAN

84.96

+0.38%↑

MRK1

120.5

+0.84%↑

SHL.DE

43.39

+1.97%↑

ARGX

769.8

-2.73%↓

PHIA

23.33

+2.73%↑

SAN

84.96

+0.38%↑

MRK1

120.5

+0.84%↑

SHL.DE

43.39

+1.97%↑

ARGX

769.8

-2.73%↓

PHIA

23.33

+2.73%↑

SAN

84.96

+0.38%↑

MRK1

120.5

+0.84%↑

SHL.DE

43.39

+1.97%↑

ARGX

769.8

-2.73%↓

PHIA

23.33

+2.73%↑

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

75 3.45

Buy Sell

Overview

Share price change

24h

Current

Min

71.3

Max

Key metrics
By Trading Economics
Income	-9.8M 25M
Sales	-17M 258M
P/E Sector Avg	14.255 80.03
Dividend yield	1.21
Profit margin	9.734
Employees	2,497
EBITDA	-12M 48M

Dividends
By Dow Jones
Dividend yield Sector Avg	1.21% 2.29%

Market Stats
By TradingEconomics
Market Cap	-50M 860M
Previous open	71.55
Previous close	75

News Sentiment

By Acuity

50%

178 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 gru 2025, 20:41 UTC

Earnings

Major Market Movers

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

4 gru 2025, 18:14 UTC

Acquisitions, Mergers, Takeovers

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

4 gru 2025, 17:43 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

4 gru 2025, 17:01 UTC

Earnings

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

4 gru 2025, 23:45 UTC

Market Talk

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

4 gru 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 gru 2025, 21:54 UTC

Market Talk

Global Equities Roundup: Market Talk

4 gru 2025, 21:54 UTC

Market Talk

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

4 gru 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

4 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 gru 2025, 21:48 UTC

Market Talk

Scales Hits Mark With Earnings Guidance -- Market Talk

4 gru 2025, 21:37 UTC

Earnings

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

4 gru 2025, 21:36 UTC

Earnings

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

4 gru 2025, 20:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 gru 2025, 20:15 UTC

Market Talk

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

4 gru 2025, 20:04 UTC

Market Talk

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

4 gru 2025, 19:54 UTC

Market Talk

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

4 gru 2025, 19:44 UTC

Acquisitions, Mergers, Takeovers

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

4 gru 2025, 19:44 UTC

Acquisitions, Mergers, Takeovers

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

4 gru 2025, 19:44 UTC

Acquisitions, Mergers, Takeovers

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

4 gru 2025, 19:33 UTC

Market Talk

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

4 gru 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

4 gru 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

4 gru 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

4 gru 2025, 19:01 UTC

Acquisitions, Mergers, Takeovers

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

4 gru 2025, 18:58 UTC

Market Talk

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

4 gru 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 gru 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4 gru 2025, 16:41 UTC

Market Talk

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

4 gru 2025, 16:33 UTC

Market Talk

Earnings

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

178 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.